Divi's Laboratories Ltd. — Call Transcript 2026

February 03, 2026

==> picture [594 x 115] intentionally omitted <==

To To The Secretary The Secretary National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East) Dalal Street Mumbai – 400051 Mumbai – 400001 Trading Symbol: DIVISLAB Scrip Code: 532488

Dear Sir / Madam,

Sub: Schedule of earnings conference call for Q3FY26

Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of earnings conference call for the quarter and nine months ended December 31, 2025, to be held on February 11, 2026 at 15.00 hrs (IST).

This is for your information and records.

Thanking You,

Yours faithfully, For Divi's Laboratories Limited

SATISH Digitally signed by SATISH CHOUDHURY CHOUDHURY MEKA Date: 2026.02.03 16:01:41 MEKA +05'30'

M. Satish Choudhury

Company Secretary & Compliance Officer

==> picture [591 x 60] intentionally omitted <==

==> picture [594 x 115] intentionally omitted <==

ANNOUNCEMENT

Divi’s Labs to release unaudited financial results for the quarter and nine months ended December 31, 2025 (Q3FY26) on February 11, 2026

Schedule of earnings conference call: February 11, 2026, at 15:00 hrs (IST)

Post release of unaudited financial results for the quarter and nine months ended December 31, 2025, the Management of the Company will host an earnings conference call on February 11, 2026, at 15:00 hrs (IST) to discuss the Company’s financial performance. A transcript of the conference call will be available at the Company’s website: www.divislabs.com.

Earnings Conference call Dial-in Information:

Option 1: Express Join with DiamondPass™

Pre-register and join without waiting for the operator: Click on the link for DiamondPass Registration.

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6043970&linkSecurityString=308bdbf004

Option 2: Join through below Dial-In Numbers

To participate in the audio call, please dial the numbers provided above about five minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call.

For further information, please contact:

Investor Relations: Mobile: +91 91542 18881 Phone: +91 40 66966352

==> picture [591 x 60] intentionally omitted <==